No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
12 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
96 (estimated)
Sponsor
Harvard Pilgrim Health Care · Other
Who this trial is looking for
This trial is looking for adolescents with type 1 diabetes who want support in managing their condition. Participants may receive financial rewards for reaching diabetes management goals. They will be compared to a group receiving standard care.
Are You a Good Fit for This Trial?
You may be able to join if
I have been diagnosed with type 1 diabetes for at least 12 months.
I use a continuous glucose monitor (CGM).
I use my CGM less than or equal to 70% of the time.
I take insulin 3 times a day or less.
I can use a mobile phone to get updates and information.
I can share my glucose and insulin data with my care team.
I can participate in the study and complete surveys.
My caregiver is willing to participate and complete surveys.
You may not be able to join if
I use my CGM more than 70% of the time.
I take insulin more than 3 times a day.
I am not interested in using technology to track my insulin.
I am not able to participate due to cognitive or physical issues.
I am a ward of the state.
I have serious other health conditions that affect my diabetes care.
My caregiver does not want to take part in the study.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes.
Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study. Researchers will compare changes in glucose levels, as w…
The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes.
Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study. Researchers will compare changes in glucose levels, as well as adolescent and caregiver person-reported outcomes between groups.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with type 1 diabetes ≥12 months
* Utilize a continuous glucose monitor (CGM) to support diabetes management
* Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3 times a …
Inclusion Criteria:
* Diagnosed with type 1 diabetes ≥12 months
* Utilize a continuous glucose monitor (CGM) to support diabetes management
* Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3 times a day
* Are using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
* Cognitively able to participate in incentive program and complete surveys
* Have access to a mobile phone to receive information about goal attainment and incentive updates
* Have the ability to upload glucose and insulin administration data remotely per processes used by participant's diabetes care team
* Caregivers are willing to participate in study and complete surveys
Exclusion Criteria:
* At time of screening, average CGM wear is greater than 70% of the time or baseline average insulin bolus administration is greater than 3 times a day
* Adolescent is not interested in using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
* Cognitively or physically unable to participate
* Adolescent is a ward of the state
* Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes
* Caregivers are not willing to participate in study and complete surveys
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.